Psychedelic treatment options for mental health.
InsideOut with Mike Alkire
English - March 29, 2022 12:00 - 20 minutes - 18.8 MBMedicine Health & Fitness Business chronicdisease covid19 healthpolicy nursing pharmaceutical chroniccondition clinician coronavirus doctor drugshortage Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Swinging for the fences: A new mindset for cancer drug development.
Next Episode: The New Frontier of Digital Marketing
On this episode of InsideOut, we chat with Rob Barrow, CEO of the pharma development company, MindMed. MindMed has been on a quest to bring psychedelic-inspired pharmaceuticals to mainstream healthcare, and Rob believes the time is right for a radical new approach to solving some of the most challenging mental health issues the world has ever faced.